| 401 |
|
CHEMOKINES - T-lymphocyte production of macrophage inflammatory protein-1a is critical to the recruitment of CD8+ T cells to the liver, lung, and spleen during graft-versus-host disease/
|
Serody, J S
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 402 |
|
CHEMOKINES - Transgenic overexpression of the CC chemokine CCL21 disrupts T-cell migration/
|
Christopherson II, K W
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 403 |
|
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy/
|
Pardanani, A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 404 |
|
Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses/
|
Li, H. Y
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 405 |
|
CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial/
|
Osby, E
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 406 |
|
Chromatin immunoprecipitation (ChIP) studies indicate a role for CCAAT enhancer binding proteins alpha and epsilon (C/EBPalpha and C/EBPepsilon) and CDP/cut in myeloid maturation-induced lactoferrin gene expression/
|
Khanna-Gupta, A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 407 |
|
Chromosomal abnormalities in Ph^- cells of patients on imatinib/
|
McMullin, M. F
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 408 |
|
Chronic lymphocytic leukemias utilizing the V~H3-21 gene display highly restricted V~L~a~m~b~d~a2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope/
|
Tobin, G
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 409 |
|
Chronic myelomonocytic leukemia/
|
Maslak, P
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 410 |
|
Chronic renal failure: a nonmalignant late effect of allogeneic stem cell transplantation/
|
Vincent, F
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 411 |
|
Classification of pediatric acute lymphoblastic leukemia by gene expression profiling/
|
Ross, M. E
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 412 |
|
Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax/
|
Cao, X
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 413 |
|
Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type/
|
Conconi, A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 414 |
|
Clinical and biologic implications of recurrent genomic aberrations in myeloma/
|
Fonseca, R
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 415 |
|
Clinical and molecular characterization of 6 patients affected by severe deficiency of coagulation factor V: broadening of the mutational spectrum of factor V gene and in vitro analysis of the newly identified missense mutations/
|
Montefusco, M. C
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 416 |
|
Clinical consequences of iron overload in hemochromatosis homozygotes/
|
Ajioka, R. S
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 417 |
|
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series/
|
Smith, S. M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 418 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND INTERVENTIONS, AND THERAPEUTIC TRIALS - An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia/
|
White, B
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 419 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND INTERVENTIONS, AND THERAPEUTIC TRIALS - Asymptomatic hemochromatosis subjects: Genotypic and phenotypic profiles/
|
Sham, R L
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 420 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND INTERVENTIONS, AND THERAPEUTIC TRIALS - Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: A single-institution study of 200 patients/
|
Salven, P
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|